SIRT6 and Miyoshi myopathy: Indeed, either depletion of SIRT6 or SIRT6-specific inhibitor OSS_128167 increases sensitivity to melphalan and doxorubicin in MM cells, and MEK1/2 inhibitors or RSK2 inhibitor abrogate sensitization to DNA-damaging agents in SIRT6-depleted cells114.